Skip to main content

Commercial genomics inquiry


The Science and Technology Committee launches an inquiry into commercial genomic testing to establish what safeguards need to be put in place to protect those who get tested.

Reports, special reports and government responses

No reports or special reports published.

Oral evidence transcripts

View all oral evidence transcripts
28 October 2019
Inquiry Commercial genomics inquiry
Witnesses Carla Newell, Chief Legal Officer and Chief Risk Officer,, Avi Lasarow, Chief Executive Officer, DNAfit, and Kathy Hibbs, Chief Legal and Regulatory Officer, 23andMe
Oral Evidence
15 October 2019
Inquiry Commercial genomics inquiry
Witnesses Dr Matthew Hurles, Head of Human Genetics and Senior Group Leader, Wellcome Sanger Institute, Professor Anna Middleton, Chair, Association of Genetic Nurses and Counsellors, Professor Anneke Lucassen, Chair, British Society for Genetic Medicine
Oral Evidence
Dr Susie Cooke (CGN0088)
EthicsAndGenetics (CGN0087)
Down's Syndrome Association (CGN0085)

Other publications

No other publications published.

Contact us

We can’t usually help you with an individual problem or a specific complaint.

  • Email:
  • Phone: 020 7219 5023 (general enquiries) | 020 7219 4984 (media enquiries)
  • Address: Science, Innovation and Technology Committee, House of Commons, London, SW1A 0AA